Numerai GP LLC purchased a new stake in Constellium SE (NYSE:CSTM - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 41,597 shares of the industrial products company's stock, valued at approximately $427,000.
Several other institutional investors also recently modified their holdings of the company. T. Rowe Price Investment Management Inc. boosted its holdings in Constellium by 26.7% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 19,828,738 shares of the industrial products company's stock valued at $203,642,000 after purchasing an additional 4,181,823 shares during the period. Janus Henderson Group PLC lifted its holdings in shares of Constellium by 4.8% during the 4th quarter. Janus Henderson Group PLC now owns 6,445,290 shares of the industrial products company's stock worth $66,193,000 after acquiring an additional 292,335 shares during the period. Nut Tree Capital Management LP lifted its holdings in shares of Constellium by 52.8% during the 4th quarter. Nut Tree Capital Management LP now owns 5,500,000 shares of the industrial products company's stock worth $56,485,000 after acquiring an additional 1,900,000 shares during the period. Millennium Management LLC lifted its holdings in shares of Constellium by 33.5% during the 4th quarter. Millennium Management LLC now owns 2,481,878 shares of the industrial products company's stock worth $25,489,000 after acquiring an additional 622,367 shares during the period. Finally, D. E. Shaw & Co. Inc. lifted its holdings in shares of Constellium by 112.2% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 2,426,033 shares of the industrial products company's stock worth $24,915,000 after acquiring an additional 1,282,587 shares during the period. 92.59% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Separately, Deutsche Bank Aktiengesellschaft upgraded shares of Constellium from a "hold" rating to a "buy" rating and set a $15.00 price objective for the company in a research report on Tuesday, February 25th.
Get Our Latest Report on Constellium
Constellium Stock Up 3.3%
NYSE CSTM traded up $0.39 on Monday, hitting $12.16. 1,605,554 shares of the company were exchanged, compared to its average volume of 1,437,229. The company has a market cap of $1.74 billion, a PE ratio of 38.00 and a beta of 1.65. Constellium SE has a 12 month low of $7.33 and a 12 month high of $22.00. The stock has a fifty day moving average of $10.18 and a 200-day moving average of $10.62. The company has a current ratio of 1.28, a quick ratio of 0.52 and a debt-to-equity ratio of 1.93.
Constellium (NYSE:CSTM - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The industrial products company reported $0.26 earnings per share for the quarter, beating analysts' consensus estimates of $0.07 by $0.19. The firm had revenue of $1.98 billion for the quarter, compared to analyst estimates of $1.88 billion. Constellium had a net margin of 0.67% and a return on equity of 4.83%. The business's quarterly revenue was up 5.3% compared to the same quarter last year. During the same period last year, the firm earned $0.11 earnings per share. As a group, analysts forecast that Constellium SE will post 1.1 earnings per share for the current year.
Constellium Profile
(
Free Report)
Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the packaging, aerospace, automotive, defense, and other transportation and industry end-markets. The company operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry.
Featured Articles

Before you consider Constellium, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Constellium wasn't on the list.
While Constellium currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.